Back
Open Access

Panel discussion: how to start treatment with SGLT2 inhibitors in patients with heart failure

Session: Practical guidance to implement heart failure treatment with SGLT2 inhibitors in the outpatient setting
Topic: Treatment
Speaker: Doctor S. Zieroth (Winnipeg, CA)
Sponsored by Boehringer Ingelheim and Eli Lilly and Company
Event: ESC Congress 2023

Congress Presentation

Add to my library

Like

About the speaker

Doctor Shelley Zieroth

University of Manitoba, Winnipeg (Canada)
56 presentations
3 followers

5 more presentations in this session

Welcome and introduction

Speaker: Professor S. Anker (Berlin, DE)

Access
Slides
Video
Like
Thumbnail

2023 heart failure guideline recommandations: how to move forward?

Speaker: Professor T. McDonagh (London, GB)

Access
Slides
Video
Like
Thumbnail

Initiating SGLT2 inhibitors in patients with HFrEF: where in the sequence do they fit?

Speaker: Professor J. Butler (Dallas, US)

Access
Slides
Video
Like
Thumbnail

Initiating SGLT2 inhibitors in patients with HFpEF: we can't treat what we can't see

Speaker: Doctor M. Costanzo (Naperville, US)

Access
Slides
Video
Like
Thumbnail

Audience questions and close

Access
Slides
Video
Like
Thumbnail

Access the full session

Practical guidance to implement heart failure treatment with SGLT2 inhibitors in the outpatient setting

Speakers: Doctor S. Zieroth, Professor S. Anker, Professor T. McDonagh, Professor J. Butler, Doctor M. Costanzo
Access
Video
Like
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources